Exchange: NASDAQ·Updated 02:29 AM EDT
IMMP logo

IMMPImmutep LTD ADR

$0.426
$0.0164
(3.71%)
Overnight
Prev Close $0.4424
EarningsSep 2
Mkt Cap$65.2M
Vol580,395.00

About

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Immutep Limited - ADR?
What is the 52-week high for Immutep Limited - ADR?
What is the 52-week low for Immutep Limited - ADR?
What is Immutep Limited - ADR stock price today?
What was Immutep Limited - ADR stock price yesterday?
What is the PE ratio of Immutep Limited - ADR?
What is the Price-to-Book ratio of Immutep Limited - ADR?
What is the 50-day moving average of Immutep Limited - ADR?